Categories Uncategorized

Astiva Health Inc. Reshaping Landscape of Healthcare by Prioritizing Patient Engagement

  • Patient engagement can lead to reduced hospitalizations as well as improved effectiveness, efficiency, quality of health services, quality of life and responsiveness
  • Healthcare industry players should address patient engagement as an imperative strategy
  • Astiva Health recognizes that successful treatment outcomes are largely dependent on the patient, with 90% of treatment success attributed to patient involvement

Growing research shows that patient engagement (“PE”) can have a significant impact on the outcome of a patient’s treatment. Recognizing that, Astiva Health is leading the way in offering a Medicare Advantage Prescription Drug (“MAPD”) health plan committed to reshaping the landscape of personalized and comprehensive healthcare by involving patients more completely in their own treatment.

“Over the past two decades, the use of patient experiences in assessing the quality of care from a patient perspective has received more attention,” states a study published in the “Journal of Patient Experience” (https://ibn.fm/HM3QE). Titled “Impact of Patient Engagement on Healthcare Quality: A Scoping Review,” the article notes that it is not only possible “to involve patients in delivery or redesign of healthcare, such engagement can lead to a reduction in the number of hospitalizations, improved effectiveness, efficiency, quality of health services, quality of life, and responsiveness.

“It increases patient awareness and health literacy, so patients’ satisfaction are improved,” the article continues. “Engagement in health improves patients’ behaviors and improves health outcomes. Also, PE can affect the costs and other aspects. Engaged patients can improve health outcomes and transform healthcare.”

The study notes that healthcare industry players should address patient engagement as an imperative strategy, going on to note that evidence indicated that PE improves patient adherence and compliance with clinical protocols. “According to healthcare quality concepts, patient centeredness, patient education and empowerment are recognized as key component in improving the quality and delivery of health services,” the article states.

“Patients are defined as one of the crucial stakeholders of healthcare and decision-making, and this shows the need for involving them in the treatment process,” the report continues. “It is an ideal healthcare situation in which patients are well informed and motivated to be involved in their own medical care, and it is a means of ensuring that patients are provided the right care appropriate to the individual characteristics, needs, preferences, and conditions of the patients.”

Astiva Health is committed to the ideal of patient engagement. The health plan innovator recognizes that successful treatment outcomes are largely dependent on the patient, with 90% of treatment success attributed to patient involvement. The company is committed to encouraging and supporting effective communication between doctors and patients, knowing that this type of collaboration is essential to building trust, fostering a cooperative relationship and ensuring patient engagement.

In addition, Astiva Health is focused on providing tools that educate patients, ensuring that they are enrolled in appropriate care programs. The company also understands that continuous monitoring is a key component to successful healthcare, and Astiva Health offers a plan that facilitates this type of monitoring through primary care.

Astiva Health cares about its members and works to establish lifelong relationships with members by providing a tailored approach to healthcare. That tailored approach includes offering multilingual solutions for customer service, marketing materials and educational resources. Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…

27 minutes ago

Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium

The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…

1 hour ago

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face…

3 days ago

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…

4 days ago

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…

6 days ago

Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…

6 days ago